- Home
- FONR vs CLYM Comparison
FONR vs CLYM Comparison
Compare FONR & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- CLYM
- Stock Information
- Founded
- FONR 1978
- CLYM 2018
- Country
- FONR United States
- CLYM United States
- Employees
- FONR N/A
- CLYM N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CLYM
- Sector
- FONR Health Care
- CLYM
- Exchange
- FONR Nasdaq
- CLYM NYSE
- Market Cap
- FONR 77.1M
- CLYM 83.8M
- IPO Year
- FONR 1987
- CLYM 2021
- Fundamental
- Price
- FONR $16.08
- CLYM $1.51
- Analyst Decision
- FONR
- CLYM Buy
- Analyst Count
- FONR 0
- CLYM 1
- Target Price
- FONR N/A
- CLYM $10.00
- AVG Volume (30 Days)
- FONR 31.0K
- CLYM 389.9K
- Earning Date
- FONR 05-15-2025
- CLYM 08-13-2025
- Dividend Yield
- FONR N/A
- CLYM N/A
- EPS Growth
- FONR N/A
- CLYM N/A
- EPS
- FONR 1.28
- CLYM N/A
- Revenue
- FONR $103,018,089.00
- CLYM N/A
- Revenue This Year
- FONR N/A
- CLYM N/A
- Revenue Next Year
- FONR N/A
- CLYM N/A
- P/E Ratio
- FONR $12.47
- CLYM N/A
- Revenue Growth
- FONR 0.29
- CLYM N/A
- 52 Week Low
- FONR $12.00
- CLYM $1.05
- 52 Week High
- FONR $18.68
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- FONR 64.00
- CLYM N/A
- Support Level
- FONR $15.80
- CLYM N/A
- Resistance Level
- FONR $16.30
- CLYM N/A
- Average True Range (ATR)
- FONR 0.48
- CLYM 0.00
- MACD
- FONR 0.02
- CLYM 0.00
- Stochastic Oscillator
- FONR 73.61
- CLYM 0.00
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.